Skip to content

Evaluation of the left atrium during stress echocardiography for the diagnosis of Ischemic Heart Disease

Left atrial strain during stress echocardiography for the assessment of Myocardial Ischemia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-33nfry3
Enrollment
Unknown
Registered
2023-07-03
Start date
2023-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Ischemia

Interventions

This is a unicentric, cross-sectional study to be developed at the Complexo Hospital de Clínicas of the Federal University of Paraná (CHC-UFPR). 45 patients, between februrary 2023 and february 2024,
with a ratio of positive and negative cases of 1:4) will undergo a complete transthoracic echocardiogram and then a pharmacological stress test with dobutamine/atropine (cineloops will be acquired at
with low doses of dobutamine - 5 to 20 mcg.kg/min -, high doses of dobutamine - 20 to 40 mcg/kg/min -, and recovery
infusion of atropine 0.25 mg will be allowed during the high dose phase if the patient does not reach submaximal heart rate). The images will be archived and post-processing will be performed using sp
E01.370.350.130.750.228

Sponsors

Complexo Hospital de Clínicas da Universidade Federal do Paraná
Lead Sponsor
Complexo Hospital de Clínicas da Universidade Federal do Paraná
Collaborator

Eligibility

Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients undergoing stress echocardiography for assessing Myocardial Ischemia due to chest pain or dyspnea; both genders; age between 18-80 years old; Left ventricular ejection fraction greater than 50%

Exclusion criteria

Exclusion criteria: Patient refusal; limitations for assessing left ventricular function by echocardiography; left ventricular ejection fraction less then 50%; prosthetic valves or valve disease graded as moderate or severe; atrial fibrillation; allergy or abnormal reaction to dobutamine; exclusion criteria for the use of atropine during dobutamine stress echocardiography are glaucoma and obstructive prostatic disease, in which case only dobutamine is used as a pharmacological stressor

Design outcomes

Primary

MeasureTime frame
Evaluate the accuracy of left atrial longitudinal strain for detection of myocardial ischemia;Evaluate the accuracy of left atrial longitudinal strain for detection of myocardial ischemia

Secondary

MeasureTime frame
Evaluate the distribution of left atrial longitudinal strain values ??at rest and after stress (pharmacological with dobutamine/atropine) in patients of low, moderate and high cardiovascular risk.;Evaluate the correlation of left atrial longitudinal strain with the pretest probability of coronary artery disease;Evaluate the distribution of left atrial longitudinal strain values ??at rest and after stress (pharmacological with dobutamine/atropine) in patients of low, moderate and high cardiovascular risk.;Evaluate the correlation of left atrial longitudinal strain with the pretest probability of coronary artery disease

Countries

Brazil

Contacts

Public ContactEduardo Bonotto

Complexo Hospital de Clínicas da Universidade Federal do Paraná

eduardobonotto@yahoo.com.br+55(41)996612006

Outcome results

None listed

Source: REBEC (via WHO ICTRP)